Negative autoregulation of c-myc gene expression is inactivated in transformed cells
- PMID: 2249657
- PMCID: PMC552162
- DOI: 10.1002/j.1460-2075.1990.tb07612.x
Negative autoregulation of c-myc gene expression is inactivated in transformed cells
Abstract
Negative feedback regulation of c-myc gene expression has been observed in some, but not all, cell types. In order to demonstrate conclusively the existence of this mechanism and gain insight into the cause of its inactivation, we have directly examined its function in B cells and then investigated its activity in a number of cell types. We demonstrate the existence of negative c-myc autoregulation by showing the rapid, dose dependent and reversible suppression of endogenous c-myc expression in EBV-immortalized B lymphoblastoid cells transfected with a c-myc gene expressed under the control of a heavy metal inducible promoter. Autoregulation occurs at the level of transcriptional initiation and is mediated by at least one stable intermediate or cofactor molecule. The c-myc autoregulatory mechanism was found operative in all (11 of 11) non-tumorigenic cells tested, including normal and immortalized lymphocytes and fibroblasts. However, this mechanism was found to be inactive in all (10 of 10) tumor cell lines derived from a variety of tissues including those carrying normal and oncogenically activated c-myc genes. These data establish the existence of an important regulatory circuit modulating c-myc expression in normal cells and suggest that its inactivation may represent a general regulatory disturbance of transformed cells.
Similar articles
-
Negative autoregulation of c-myc transcription.EMBO J. 1990 Apr;9(4):1113-21. doi: 10.1002/j.1460-2075.1990.tb08217.x. EMBO J. 1990. PMID: 2182320 Free PMC article.
-
Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.Oncogene. 1997 Oct 16;15(16):1937-46. doi: 10.1038/sj.onc.1201363. Oncogene. 1997. PMID: 9365240
-
Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice.Oncogene. 1989 May;4(5):593-600. Oncogene. 1989. PMID: 2657574
-
The role of myc oncogenes in cell growth and differentiation.Adv Dent Res. 1990 Jun;4:69-79. doi: 10.1177/08959374900040011001. Adv Dent Res. 1990. PMID: 2206213 Review.
-
c-MYC-induced genomic instability.Cold Spring Harb Perspect Med. 2014 Apr 1;4(4):a014373. doi: 10.1101/cshperspect.a014373. Cold Spring Harb Perspect Med. 2014. PMID: 24692190 Free PMC article. Review.
Cited by
-
Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.Immunogenetics. 1994;40(1):54-61. doi: 10.1007/BF00163964. Immunogenetics. 1994. PMID: 8206526
-
Initiation of transcription from the minute virus of mice P4 promoter is stimulated in rat cells expressing a c-Ha-ras oncogene.J Virol. 1991 Sep;65(9):4919-28. doi: 10.1128/JVI.65.9.4919-4928.1991. J Virol. 1991. PMID: 1651412 Free PMC article.
-
Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.EMBO J. 1996 Sep 16;15(18):4949-58. EMBO J. 1996. PMID: 8890168 Free PMC article.
-
Myc is an essential negative regulator of platelet-derived growth factor beta receptor expression.Mol Cell Biol. 2000 Sep;20(18):6768-78. doi: 10.1128/MCB.20.18.6768-6778.2000. Mol Cell Biol. 2000. PMID: 10958674 Free PMC article.
-
Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas.Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15018-23. doi: 10.1073/pnas.232581199. Epub 2002 Oct 29. Proc Natl Acad Sci U S A. 2002. PMID: 12407182 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources